Transarterial chemoembolization plus sorafenib versus sorafenib for intermediate-advanced hepatocellular carcinoma A meta-analysis comparing clinical outcomes

Xie, Y; Tian, H; Xiang, B; Zhang, YJ; Liu, J; Cai, ZY; Xiang, H

Xiang, H (corresponding author), Hunan Normal Univ, Dept Intervent Radiol & Vasc Surg, Affiliated Hosp 1, Changsha 410005, Peoples R China.

MEDICINE, 2021; 100 (33):

Abstract

Background: Hepatocellular carcinoma (HCC) ranks as the sixth most common cancer and the second leading cause of cancer-related death worldwide, local......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索